Blood

Vol. 147, Issue 9 Issue 9 2026
15
Articles

Articles in this Issue

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load

Cathelijne Fokkema, Luca Bertamini, Madelon M. E. de Jong et al. Feb 26, 2026 pp. 932-945 10.1182/blood.2025030083

Abstract High levels of circulating tumor cells (CTC) are a powerful predictor of poor outcomes in newly diagnosed multiple myeloma, yet the mechanistic underpinnings of this corre...

What's in a name? HLH/hyperinflammatory syndromes

Sarah Nikiforow, Nancy Berliner Feb 26, 2026 pp. 909-910 10.1182/blood.2025032344

Advancing the classification of hematolymphoid neoplasms together: for patients, medicine, and science

Robert P. Hasserjian, Joseph D. Khoury, Carlos Bueso-Ramos et al. Feb 26, 2026 pp. 915-919 10.1182/blood.2025030689

Abstract A single, universally used tumor classification system is critical to ensure precision in patient care, clinical trial enrollment, and advancing therapy. Since the publica...

Platelet defects in patients and mice with Ehlers-Danlos syndrome

Mariia Kumskova, Gagan D. Flora, Manasa K. Nayak et al. Feb 26, 2026 pp. 987-997 10.1182/blood.2025029912

Abstract Ehlers-Danlos syndrome (EDS) is a group of connective tissue disorders characterized by joint hypermobility, skin hyperelasticity, perivascular tissue fragility, easy brui...

CD38+ monocytes fuel fibrosis in myeloproliferative neoplasm

Alban Johansson, Steven W. Lane Feb 26, 2026 pp. 907-909 10.1182/blood.2025032444

From nothing to abundance for hemophilia with inhibitors

Guy Young Feb 26, 2026 pp. 905-906 10.1182/blood.2025031960

Slowing the cell cycle to increase fetal hemoglobin

Patrick G. Gallagher Feb 26, 2026 pp. 911-912 10.1182/blood.2025032404

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

Joseph M. Rocco, Joseph H. Oved, Rikita J. Patel et al. Feb 26, 2026 pp. 960-972 10.1182/blood.2025030976

Abstract Hemophagocytic lymphohistiocytosis (HLH) is an interferon gamma–driven hyperinflammatory syndrome with high morbidity and mortality. Identifying reliable prognostic biomar...

Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial

Davide Matino, Suchitra S. Acharya, Carrie Turich Taylor et al. Feb 26, 2026 pp. 920-931 10.1182/blood.2025031065

Abstract Marstacimab, a monoclonal antibody that inhibits tissue factor pathway inhibitor, is approved for prophylactic use in individuals with hemophilia A or B without inhibitors...

At a crossroads: circulating tumor cells in myeloma

Jean-Baptiste Alberge Feb 26, 2026 pp. 906-907 10.1182/blood.2025032333

EDS: from Hippocrates to hyporeactive platelets

James D. McFadyen Feb 26, 2026 pp. 912-913 10.1182/blood.2025032331

The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms

Yiru Yan, Jinqin Liu, Songyang Zhao et al. Feb 26, 2026 pp. 946-959 10.1182/blood.2025028703

Abstract Proinflammatory signaling is a hallmark of myeloproliferative neoplasms. Several studies have shown that monocytes are a major source of proinflammatory cytokines and that...

CD25+ mast cell hyperplasia in myeloid/lymphoid neoplasm with <i>PDGFRA</i> rearrangement mimicking systemic mastocytosis

Beenu Thakral, Sanam Loghavi Feb 26, 2026 pp. 1004-1004 10.1182/blood.2025031870

p27Kip1 regulates γ-globin production

Ginette Balbin-Cuesta, Claire Drysdale, Claire Kerpet et al. Feb 26, 2026 pp. 973-986 10.1182/blood.2025028895

Abstract Sickle cell disease (SCD) and β-thalassemia are devastating genetic disorders resulting from defects in the β-globin subunit of adult hemoglobin. Both disorders are amelio...

Somatic genetic rescue in <i>ZCCHC8</i> -associated telomere biology disorders

Sophie de Tocqueville, Flavia Donaires, Nicholas DeCleene et al. Feb 26, 2026 pp. 998-1003 10.1182/blood.2025031248

Abstract We show that somatic genetic rescue is frequent in telomere biology disorders (TBDs) caused by germ line ZCCHC8 variants. Our results highlight the critical intrinsic role...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page